180.00
-4(-2.17%)
Currency In JPY
Address
MetLife Shin-Yokohama Building
Yokohama, 222-0033
Japan
Phone
81 45 475 3887
Website
Sector
Healthcare
Industry
Biotechnology
Employees
96
First IPO Date
June 26, 2013
| Name | Title | Pay | Year Born |
| Dr. Shuji Yokoyama Ph.D. | Chief Executive Officer, President & Representative Director | 0 | 1968 |
| Mr. Ramakrishna V. Modali | Chief Executive Officer of REPROCELL USA Ltd & CEO of Bioserve Biotechnologies India | 0 | N/A |
| Dr. David Bunton | Chief Executive officer of REPROCELL Europe | 0 | N/A |
| Mr. Daisuke Usui | Chief Operating Officer & Director | 0 | 1973 |
ReproCELL Incorporated operates as a stem cell research company in Japan. It offers stem cell reagents, including RNA reprogramming, small molecules, growth factors and cytokines, antibodies and staining kits, pluripotent stem cell culture media, cell substrates, cryopreservation media, dissociation solution, and transfection reagents; differentiated induced pluripotent stem cell (iPSC) and related reagents, feeder cells, and induced neurons; and 3D cell culture; and labware. The company also provides preclinical genomics, stem cell research, drug efficacy, safety, & ADME, human tissue samples, therapeutic pipeline, clinical laboratory services, clinical diagnostic services, and gmp ipsc master cell bank services. ReproCELL Incorporated was incorporated in 2003 and is based in Yokohama, Japan.